Future of oncologic photodynamic therapy

dc.creatorAllison, Ron R.
dc.creatorBagnato, Vanderlei Salvador
dc.creatorSibata, Claudio H.
dc.date.accessioned2016-03-11T14:03:41Z
dc.date.accessioned2018-07-04T16:53:06Z
dc.date.available2016-03-11T14:03:41Z
dc.date.available2018-07-04T16:53:06Z
dc.date.created2016-03-11T14:03:41Z
dc.date.issued2010
dc.identifierFuture Oncology,London : Future Medicine,v. 6, n. 6, p. 929-940, 2010
dc.identifier1479-6694
dc.identifierhttp://www.producao.usp.br/handle/BDPI/49941
dc.identifier10.2217/FON.10.51
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1641689
dc.description.abstractPhotodynamic therapy (PDT) is a tumor-ablative and function-sparing oncologic intervention. The relative simplicity of photosensitizer application followed by light activation resulting in the cytotoxic and vasculartoxic photodynamic reaction has allowed PDT to reach a worldwide audience. With several commercially available photosensitizing agents now on the market, numerous well designed clinical trials have demonstrated the efficacy of PDT on various cutaneous and deep tissue tumors. However, current photosensitizers and light sources still have a number of limitations. Future PDT will build on those findings to allow development and refinement of more optimal therapeutic agents and illumination devices. This article reviews the current state of the art and limitations of PDT, and highlight the progress being made towards the future of oncologic PDT.
dc.languageeng
dc.publisherFuture Medicine
dc.publisherLondon
dc.relationFuture Oncology
dc.rightsCopyright Future Medicine
dc.rightsrestrictedAccess
dc.subjectFuture
dc.subjectPhotodynamic therapy
dc.subjectPhotosensitizer
dc.titleFuture of oncologic photodynamic therapy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución